Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-10 23:13:26 UTC
Update Date2021-09-26 22:55:05 UTC
HMDB IDHMDB0246188
Secondary Accession NumbersNone
Metabolite Identification
Common Name2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid
Description2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid, also known as estradiol-6-(O-carboxymethyl)oxime or estradiol-6-cmo, belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Based on a literature review very few articles have been published on 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2-[(3,17-dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7h-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetateGenerator
2-[({5,14-dihydroxy-15-methyltetracyclo[8.7.0.0,.0,]heptadeca-2(7),3,5-trien-8-ylidene}amino)oxy]acetateHMDB
Estradiol-6-(O-carboxymethyl)oximeHMDB
Estradiol-6-cmoHMDB
Estrone-6-(O-carboxymethyl)oximeHMDB
((((17 beta)-3,17-Dihydroxyestra-1,3,5(10)-trien-6-ylidene)amino)oxy)acetic acidHMDB
2-[(e)-[(8S,9R,13R,14R,17R)-3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene]amino]oxyacetateHMDB
Chemical FormulaC20H25NO5
Average Molecular Weight359.422
Monoisotopic Molecular Weight359.173272909
IUPAC Name2-[({5,14-dihydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-8-ylidene}amino)oxy]acetic acid
Traditional Name[({5,14-dihydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-8-ylidene}amino)oxy]acetic acid
CAS Registry NumberNot Available
SMILES
CC12CCC3C(CC(=NOCC(O)=O)C4=C3C=CC(O)=C4)C1CCC2O
InChI Identifier
InChI=1S/C20H25NO5/c1-20-7-6-13-12-3-2-11(22)8-15(12)17(21-26-10-19(24)25)9-14(13)16(20)4-5-18(20)23/h2-3,8,13-14,16,18,22-23H,4-7,9-10H2,1H3,(H,24,25)
InChI KeyAWARIMYXKAIIGO-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassEstrane steroids
Direct ParentEstrogens and derivatives
Alternative Parents
Substituents
  • Estrogen-skeleton
  • 17-hydroxysteroid
  • Hydroxysteroid
  • 3-hydroxysteroid
  • Phenanthrene
  • Tetralin
  • 1-hydroxy-2-unsubstituted benzenoid
  • Benzenoid
  • Cyclic alcohol
  • Secondary alcohol
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Carboxylic acid derivative
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Alcohol
  • Aromatic homopolycyclic compound
Molecular FrameworkAromatic homopolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.74ALOGPS
logP2.05ChemAxon
logS-3.9ALOGPS
pKa (Strongest Acidic)3.55ChemAxon
pKa (Strongest Basic)2.81ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area99.35 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity95.08 m³·mol⁻¹ChemAxon
Polarizability39.14 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-219.80830932474
DeepCCS[M+Na]+195.1630932474

Predicted Kovats Retention Indices

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #1CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O3232.3Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #1CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O3262.7Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #1CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O4113.4Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #2CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O3339.0Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #2CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O3158.2Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #2CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O4081.4Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #3CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C3261.4Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #3CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C3131.5Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TMS,isomer #3CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C3980.4Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O3273.6Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O3296.2Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O4007.0Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #2CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O[Si](C)(C)C3182.1Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #2CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O[Si](C)(C)C3273.7Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #2CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O[Si](C)(C)C3882.3Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #3CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C3289.5Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #3CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C3173.7Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TMS,isomer #3CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C3872.6Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,3TMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O[Si](C)(C)C3241.8Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,3TMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O[Si](C)(C)C3265.6Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,3TMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C)CC3C1CCC2O[Si](C)(C)C3743.5Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #1CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O3449.9Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #1CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O3534.0Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #1CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O4225.7Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #2CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O3557.5Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #2CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O3419.9Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #2CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O4211.3Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #3CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C(C)(C)C3490.0Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #3CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C(C)(C)C3401.5Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,1TBDMS,isomer #3CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C(C)(C)C4121.3Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O3669.0Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O3801.9Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O4171.6Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #2CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O[Si](C)(C)C(C)(C)C3556.6Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #2CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O[Si](C)(C)C(C)(C)C3784.9Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #2CC12CCC3C4=CC=C(O)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O[Si](C)(C)C(C)(C)C4050.7Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #3CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C(C)(C)C3694.5Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #3CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C(C)(C)C3668.5Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,2TBDMS,isomer #3CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O)CC3C1CCC2O[Si](C)(C)C(C)(C)C4067.0Standard polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,3TBDMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O[Si](C)(C)C(C)(C)C3747.7Semi standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,3TBDMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O[Si](C)(C)C(C)(C)C3959.0Standard non polar33892256
2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid,3TBDMS,isomer #1CC12CCC3C4=CC=C(O[Si](C)(C)C(C)(C)C)C=C4C(=NOCC(=O)O[Si](C)(C)C(C)(C)C)CC3C1CCC2O[Si](C)(C)C(C)(C)C3972.9Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid GC-MS (Non-derivatized) - 70eV, Positivesplash10-000x-2039000000-be3ca6a3113990628dcb2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid 10V, Negative-QTOFsplash10-0a4i-0029000000-94ce78d210fdacad94df2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid 20V, Negative-QTOFsplash10-067l-0098000000-a761451be10ae646d1ae2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid 40V, Negative-QTOFsplash10-0159-1091000000-f7f89269d6499fee4ef72021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid 10V, Positive-QTOFsplash10-03dl-0009000000-b18bf027d051e66ef5512021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid 20V, Positive-QTOFsplash10-0f6x-0179000000-2b1cbe13eb3ae31053fb2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-[(3,17-Dihydroxy-13-methyl-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-ylidene)amino]oxyacetic acid 40V, Positive-QTOFsplash10-052k-5791000000-d67fb04c2a55518194372021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4225137
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound5047478
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]